Spleen tyrosine kinase as a molecular target for treatment of leukemias and lymphomas

被引：20

作者：

Uckun, Fatih M. ^{[1
,2
]}

Qazi, Sanjive ^{[3
]}

机构：

[1] Childrens Hosp Los Angeles, Dev Therapeut Program, Inst Pediat Clin Res, Los Angeles, CA 90027 USA

[2] Univ So Calif, Dept Pediat, Div Hematol Oncol, Sch Med,Childrens Ctr Canc & Blood Dis, Los Angeles, CA 90027 USA

[3] Gustavus Adolphus Coll, St Peter, MN 56082 USA

来源：

EXPERT REVIEW OF ANTICANCER THERAPY | 2010年 / 10卷 / 09期

关键词：

leukemia; lymphoma; nanotechnology; rational drug design; RNA interference; spleen tyrosine kinase; tyrosine kinase inhibitor; ACUTE LYMPHOBLASTIC-LEUKEMIA; CELL ANTIGEN RECEPTOR; CHILDRENS-ONCOLOGY-GROUP; PRIMARY CLONOGENIC BLASTS; NON-HODGKIN-LYMPHOMA; BONE-MARROW RELAPSE; B-CELLS; PHOSPHOINOSITIDE; 3-KINASE; APOPTOTIC RESISTANCE; THERAPEUTIC TARGET;

D O I：

10.1586/ERA.10.112

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Spleen tyrosine kinase (SYK) has emerged as a potential molecular target for the treatment of B-lineage leukemias and lymphomas. Here, we provide an overview of the current state of knowledge regarding the regulatory signaling function of SYK and its role in the pathogenesis of B-lineage lymphoid malignancies, available methods and drug candidates for targeting SYK, as well as compelling preclinical and clinical evidence regarding the clinical potential of inhibiting SYK. The further development of rationally designed SYK inhibitors may provide the foundation for therapeutic innovation against B-lineage leukemias and lymphomas.

引用

页码：1407 / 1418

页数：12

共 50 条

[41] Recent advances in understanding spleen tyrosine kinase (SYK) in human biology and disease, with a focus on fostamatinib [J].

Cooper, Nichola ;

Ghanima, Waleed ;

Hill, Quentin A. ;

Nicolson, Phillip Lr ;

Markovtsov, Vadim ;

Kessler, Craig .

PLATELETS, 2023, 34 (01)

[42] Immunomodulatory role of spleen tyrosine kinase in chronic inflammatory and autoimmune diseases [J].

Zhou, Yaqi ;

Zhang, Yaowen ;

Yu, Wei ;

Qin, Yufen ;

He, Heng ;

Dai, Fengxian ;

Wang, Yibo ;

Zhu, Fengqin ;

Zhou, Guangxi .

IMMUNITY INFLAMMATION AND DISEASE, 2023, 11 (07)

[43] Spleen Tyrosine Kinase Is a Critical Regulator of Neutrophil Responses to Candida Species [J].

Negoro, Paige E. ;

Xu, Shuying ;

Dagher, Zeina ;

Hopke, Alex ;

Reedy, Jennifer L. ;

Feldman, Michael B. ;

Khan, Nida S. ;

Viens, Adam L. ;

Alexander, Natalie J. ;

Atallah, Natalie J. ;

Scherer, Allison K. ;

Dutko, Richard A. ;

Jeffery, Jane ;

Kernien, John F. ;

Fites, J. Scott ;

Nett, Jeniel E. ;

Klein, Bruce S. ;

Vyas, Jatin M. ;

Irimia, Daniel ;

Sykes, David B. ;

Mansour, Michael K. .

MBIO, 2020, 11 (03)

[44] Alzheimer's disease pathological lesions activate the spleen tyrosine kinase [J].

Schweig, Jonas Elias ;

Yao, Hailan ;

Beaulieu-Abdelahad, David ;

Ait-Ghezala, Ghania ;

Mouzon, Benoit ;

Crawford, Fiona ;

Mullan, Michael ;

Paris, Daniel .

ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2017, 5

[45] Alzheimer’s disease pathological lesions activate the spleen tyrosine kinase [J].

Jonas Elias Schweig ;

Hailan Yao ;

David Beaulieu-Abdelahad ;

Ghania Ait-Ghezala ;

Benoit Mouzon ;

Fiona Crawford ;

Michael Mullan ;

Daniel Paris .

Acta Neuropathologica Communications, 5

[46] Selective spleen tyrosine kinase inhibition delays autoimmune arthritis in mice [J].

Zhang, Zuofu ;

Cao, Chunni ;

Sun, Shui ;

Xu, Qiang .

MOLECULAR MEDICINE REPORTS, 2015, 12 (02) :2902-2906

[47] Clinical significance of elevated spleen tyrosine kinase expression in nasopharyngeal carcinoma [J].

Du, Zi-Ming ;

Kou, Chang-Wei ;

Wang, Hai-Yun ;

Huang, Ma-Yan ;

Liao, Ding-Zhun ;

Hu, Chun-Fang ;

Chen, Jing ;

Yan, Li-Xu ;

Hu, Li-Fu ;

Ernberg, Ingemar ;

Zeng, Yi-Xin ;

Shao, Jian-Yong .

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2012, 34 (10) :1456-1464

[48] Spleen Tyrosine Kinase Inhibition Ameliorates Tubular Inflammation in IgA Nephropathy [J].

Yiu, Wai Han ;

Chan, Kam Wa ;

Chan, Loretta Y. Y. ;

Leung, Joseph C. K. ;

Lai, Kar Neng ;

Tang, Sydney C. W. .

FRONTIERS IN PHYSIOLOGY, 2021, 12

[49] Inhibitors of switch kinase 'spleen tyrosine kinase' in inflammation and immune-mediated disorders: A review [J].

Kaur, Maninder ;

Singh, Manjinder ;

Silakari, Om .

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 67 :434-446

[50] Mutations in tyrosine kinase and tyrosine phosphatase and their relevance to the target therapy in hematologic malignancies [J].

Zhu, Ni ;

Xiao, Haowen ;

Wang, Li-Mengmeng ;

Fu, Shan ;

Zhao, Chan ;

Huang, He .

FUTURE ONCOLOGY, 2015, 11 (04) :659-673

← 1 2 3 4 5 →